Centene Shares Drop 40% Amid Guidance Withdrawal and Medicaid Challenges
Shares of Centene plummeted over 32% after the company withdrew its 2025 guidance due to poor risk adjustment results and ongoing cost pressures, leading Wall Street to downgrade ratings and cut price targets, highlighting challenges in its ACA exchange and Medicaid segments.